What Researchers Did
Researchers conducted a review of existing in vivo and clinical data to evaluate the potential benefits and effectiveness of hyperbaric oxygen therapy (HBOT) for middle cerebral artery occlusion (MCAO) and cerebral ischemia/reperfusion injury.
What They Found
The review found evidence from animal and clinical studies suggesting positive effects of hyperbaric oxygen therapy (HBOT) on neurological outcomes following cerebral ischemia. However, the review also highlighted conflicting evidence, with some studies indicating that HBOT may not improve functional recovery after ischemic injury.
What This Means for Canadian Patients
For Canadian patients experiencing ischemic stroke due to middle cerebral artery occlusion, hyperbaric oxygen therapy (HBOT) is an area of ongoing research with mixed evidence regarding its benefits. Patients should discuss all treatment options with their healthcare providers, as current evidence does not definitively support HBOT as a standard treatment for improving functional recovery after stroke.
Canadian Relevance
This review does not have a direct Canadian connection.
Study Limitations
A limitation of the current evidence base, as highlighted by this review, is the conflicting data regarding the effectiveness of hyperbaric oxygen therapy on functional recovery after ischemic injury.